Results 171 to 180 of about 451,686 (317)

Adjusting the scent ratio: using genetically modified Vitis vinifera plants to manipulate European grapevine moth behaviour [PDF]

, 2017
Umberto Salvagnin, Mickaël Malnoy, Gunda Thöming, Marco Tasin, Silvia Carlin, Stefan Martens, Urška Vrhovšek, Sergio Angeli, Gianfranco Anfora   +8 more
openalex   +1 more source

CSF Biomarker‐Based Cognitive Trajectories in Parkinson's Disease‐Subjective Cognitive Decline

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cognitive complaints without objective cognitive impairment in Parkinson's Disease, termed Parkinson's Disease‐Subjective Cognitive Decline (PD‐SCD), have been associated with cognitive decline. However, its progression is heterogeneous, highlighting the need for improved identification of patients at greater risk for deterioration ...
Jon Rodriguez‐Antiguedad, Arnau Puig‐Davi, Iñigo Ruíz‐Barrio, Javier Pagonabarraga, Anna Vázquez‐Oliver, Andrea Horta‐Barba, Jaime Kulisevsky, Saül Martínez‐Horta   +7 more
wiley   +1 more source

Additional file 1 of Plant Co-expression Annotation Resource: a web server for identifying targets for genetically modified crop breeding pipelines

, 2021
Marcos Viana, Adhemar Zerlotini, Maurício A. Mudadu   +2 more
openalex   +2 more sources

Phenotyping Healthcare Use 2–3 Decades Before the First Multiple Sclerosis Demyelinating Event

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Phenotype hospital, physician, and emergency department (ED) visits by diagnoses and specialty up to 29 years pre‐multiple sclerosis (MS) onset versus a matched population without MS. Methods We identified people with MS (PwMS) using population‐based administrative data from Ontario, Canada (1991–2020).
Helen Tremlett, Karl Everett, Colleen J. Maxwell, Feng Zhu, Ayesha Asaf, Ping Li, Kyla A. McKay, Yinshan Zhao, Ruth Ann Marrie   +8 more
wiley   +1 more source

Qualitative detection of genetically modified organisms in plant samples

, 2007
Csilla Uri, József Prokisch, Erzsébet Sándor, Zoltán Győri   +3 more
openalex   +2 more sources

Genetically Modified Plants and Climate Change

, 2022
Babar Wadood, Tayyaba Sanaullah, Sajed Ali, Muhammad Zeeshan Abid, Altaf Hussain, Touqeer Abbas, Nazish Sajjad, Muhammad Hamid Nawaz Khan, Aamir Riaz, Muhammad Waqas   +9 more
openalex   +2 more sources

Assessment of unanticipated unintended effects of genetically modified plants on non‐target organisms: a controversy worthy of pursuit?

, 2016
Yann Devos, F. Álvarez-Alfageme, A. Gennaro, S. Mestdagh   +3 more
semanticscholar   +1 more source

Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite the availability of effective therapies for Multiple Sclerosis (MS), the unpredictable nature of disease progression and the variability in individual treatment outcomes call for reliable biomarkers. This pilot study aims to investigate the potential of plasma circulating microRNAs (miRNAs) as predictive biomarkers for ...
Fortunata Carbone, Alessandra Colamatteo, Teresa Micillo, Gianmarco Abbadessa, Silvia Garavelli, Clorinda Fusco, Claudia Russo, Francesco Perna, Federica Garziano, Claudia La Rocca, Maria Mottola, Giorgia Teresa Maniscalco, Simona Bonavita, Antonio Luca Spiezia, Alessia Castiello, Roberta Lanzillo, Vincenzo Brescia Morra, Claudio Procaccini, Paola de Candia, Giuseppe Matarese   +19 more
wiley   +1 more source

Technical Note on the quality of DNA sequencing for the molecular characterisation of genetically modified plants. [PDF]

EFSA J
European Food Safety Authority (EFSA), César-Razquin A, Casacuberta J, Dalmay T, Federici S, Jacchia S, Kagkli DM, Moxon S, Papadopoulou N.   +8 more
europepmc   +1 more source

Amyotrophic Lateral Sclerosis as a Multistep Process in the United States: A Population‐Based Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Amyotrophic lateral sclerosis (ALS) is a fatal, progressive neurodegenerative disease that typically results in death within 3–5 years from symptom onset. However, little is known about the environmental exposures, clinical aspects, or social determinants of health factors that may be associated with the disease.
Jasmine Berry, Jaime Raymond, Theodore Larson, D. Kevin Horton, Moon Han, Theresa Nair, Ammar Al‐Chalabi, Paul Mehta   +7 more
wiley   +1 more source